These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 30891102

  • 21. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N, Wang L, Yang Y, Gong L, Xiao B, Liu X.
    Biochem Biophys Res Commun; 2017 Nov 25; 493(3):1322-1328. PubMed ID: 28986250
    [Abstract] [Full Text] [Related]

  • 22. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 23. Total Blood Exosomes in Breast Cancer: Potential Role in Crucial Steps of Tumorigenesis.
    Konoshenko M, Sagaradze G, Orlova E, Shtam T, Proskura K, Kamyshinsky R, Yunusova N, Alexandrova A, Efimenko A, Tamkovich S.
    Int J Mol Sci; 2020 Oct 05; 21(19):. PubMed ID: 33027894
    [Abstract] [Full Text] [Related]

  • 24. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY, Sun L, Guo ZR, Li JC, Bai TT, Cai XX, Li WH, Zhu YF.
    J Ovarian Res; 2019 Jan 22; 12(1):6. PubMed ID: 30670062
    [Abstract] [Full Text] [Related]

  • 25. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
    Aslan C, Maralbashi S, Kahroba H, Asadi M, Soltani-Zangbar MS, Javadian M, Shanehbandi D, Baradaran B, Darabi M, Kazemi T.
    Life Sci; 2020 Oct 01; 258():118094. PubMed ID: 32673663
    [Abstract] [Full Text] [Related]

  • 26. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
    Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H.
    Cancer; 2013 Mar 15; 119(6):1159-67. PubMed ID: 23224754
    [Abstract] [Full Text] [Related]

  • 27. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M, Chacártegui Borrás J, Castiglia M, Van Der Steen N, Mertens I, Pauwels P, Peeters M, Rolfo C.
    J Vis Exp; 2016 May 27; (111):. PubMed ID: 27285610
    [Abstract] [Full Text] [Related]

  • 28. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T.
    BMC Cancer; 2018 Nov 05; 18(1):1065. PubMed ID: 30396333
    [Abstract] [Full Text] [Related]

  • 29. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals.
    Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Salo T, Vered M.
    J Cancer Res Clin Oncol; 2016 Jan 05; 142(1):101-10. PubMed ID: 26115960
    [Abstract] [Full Text] [Related]

  • 30. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T, Zhang X, Gao S, Jing F, Yang Y, Du L, Zheng G, Li P, Li C, Wang C.
    Oncotarget; 2016 Dec 20; 7(51):85551-85563. PubMed ID: 27888803
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human extracellular vesicles and correlation with two clinical forms of toxoplasmosis.
    da Cruz AB, Maia MM, Pereira IS, Taniwaki NN, Namiyama GM, Telles JPM, Vidal JE, Spegiorin LCJF, Brandão de Mattos CC, Mattos LC, Meira-Strejevitch CDS, Pereira-Chioccola VL.
    PLoS One; 2020 Dec 20; 15(3):e0229602. PubMed ID: 32126572
    [Abstract] [Full Text] [Related]

  • 33. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A.
    J Cell Physiol; 2018 Feb 20; 233(2):774-786. PubMed ID: 28109133
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum exosomal miR-200c is a potential diagnostic biomarker for breast cancer.
    Qiao P, Du H, Guo X, Yu M, Zhang C, Shi Y.
    Biomarkers; 2024 Nov 20; 29(7):419-426. PubMed ID: 39317236
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People.
    Tian F, Shen Y, Chen Z, Li R, Ge Q.
    Biomed Res Int; 2017 Nov 20; 2017():1304816. PubMed ID: 28656135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.